Bracco files patent infringement complaint against Jubilant for rubidium-82 generators

Bracco Diagnostics has filed a complaint with the U.S. International Trade Commission (ITC) against radiopharmaceutical firm Jubilant DraxImage and two affiliates, citing patent infringement on its rubidium-82 generators. 

The papers, filed March 27, argue the Canadian-based Jubilant violated the Tariff Act of 1930, and requested a cease-and-desist order to prohibit the sale of Jubilant’s Ruby elution system and Ruby-Fill rubidium-82 generators, which are commonly used in cardiac PET studies.

The request would also include Ruby elution systems and Ruby-Fill generators that have already been imported along with damages and injunctive relief.

The complaint prompted the ITC to issue an eight-day public comment period, during which the ITC will take public comments from any parties who use the technology in healthcare or have other interest. The comment period ends April 11.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.